Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 7:15:1494646.
doi: 10.3389/fphar.2024.1494646. eCollection 2024.

LC-MS/MS assisted pharmacokinetic and tissue distribution study of ropivacaine and 3-OH-ropivacaine on rats after plane block anesthesia

Affiliations

LC-MS/MS assisted pharmacokinetic and tissue distribution study of ropivacaine and 3-OH-ropivacaine on rats after plane block anesthesia

Mihaela Butiulca et al. Front Pharmacol. .

Abstract

Knowledge of drug pharmacokinetics and tissue distribution is precious for ensuring patient safety and optimizing treatments. The varied use of local anesthetics, as well as the fact that anesthetics can sometimes have low therapeutic indices and numerous adverse drug reactions, makes any novel pharmacokinetics information valuable. The present manuscript describes a pharmacokinetic study of ropivacaine carried out after plane block anesthesia on an animal model, using high sensitivity, accurate, and precise LC-MS/MS bioanalysis. Both plasmatic concentrations and tissue distribution of ropivacaine and its primary active metabolite were determined. The results showed a tissue affinity of the anesthetics, a clearance of ropivacaine mainly by hepatic metabolism, and the final, mainly renal excretion of the hydroxylated metabolite. While the results cannot simply and directly be transposed to human pharmacokinetics, they offer a valuable basis for future studies and can contribute to a better understanding of the bioavailability and toxicology of the widely used modern anesthetic.

Keywords: HPLC; LC-MS/MS; pharmacokinetics; rats; ropivacaine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Experimental protocol.
FIGURE 2
FIGURE 2
Chromatograms of ropivacaine (top) and 3-OH ropivacaine (bottom) in standard solution compared to blank samples.
FIGURE 3
FIGURE 3
Chromatograms of ropivacaine and 3-OH ropivacaine in plasma samples.
FIGURE 4
FIGURE 4
Elimination curve of ropivacaine from plasma.
FIGURE 5
FIGURE 5
Spaghetti plot of calculated tissue concentrations of ropivacaine and 3-OH-ropivacaine (concentrations are expressed in ng/g tissue, and time in hours).
FIGURE 6
FIGURE 6
Spaghetti plot of calculated tissue and plasma concentrations of ropivacaine and 3-OH-ropivacaine (concentrations are expressed in ng/g tissue, and ng/mL for plasma, and time in hours).
FIGURE 7
FIGURE 7
Maximum concentration (Cmax) of ropivacaine and 3-OH-ropivacaine in tissues and plasma (ng.mL-1).
FIGURE 8
FIGURE 8
Area under the curve to the last measurable concentration (AUClast) of ropivacaine and 3-OH-ropivacaine in tissues and plasma (ng.mL-1).
FIGURE 9
FIGURE 9
Clearance (CL) of ropivacaine and 3-OH-ropivacaine from tissues and plasma (L.h-1. kg-1).

References

    1. Brydone A. S., Souvatzoglou R., Abbas M., Watson D. G., McDonald D. A., Gill A. M. (2015). Ropivacaine plasma levels following high-dose local infiltration analgesia for total knee arthroplasty. Anaesthesia 70 (7), 784–790. 10.1111/anae.13017 - DOI - PubMed
    1. Butiulca M., Farczadi L., Vari C. E., Imre S., Pui M., Lazar A. (2023). LC-MS/MS assisted biomonitoring of ropivacaine and 3-OH-ropivacaine after plane block anesthesia for cardiac device implantation. Front. Mol. Biosci. 10, 1243103. 10.3389/fmolb.2023.1243103 - DOI - PMC - PubMed
    1. Ekstrom G., Gunnarsson U. B. (1996). Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Drug Metab. Dispos. 24, 955–961. - PubMed
    1. EMA (2011). Guideline on bioanalytical method validation. (EMEA/CHMP/EWP/192217/2009). European Medicines Agency EMA (Accessed August 2024).
    1. FDA (2018). Bioanalytical method validation guidance for industry. United Stated: FDA.

LinkOut - more resources